Literature DB >> 12033394

Simulation of the pharmacokinetic profile of methazolamide in blood: effect of erythrocyte carbonic anhydrase binding on drug disposition.

Malaz A AbuTarif1, David R Taft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12033394     DOI： 10.1023/a:1015120418178

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  12 in total

1.  Sulfenamido-sulfonamides as inhibitors of carbonic anhydrase isozymes I, II and IV.

Authors:  C T Supuran; F Briganti; A Scozzafava
Journal:  J Enzyme Inhib       Date:  1997-08

Review 2.  Erythrocytes and the transport of drugs and endogenous compounds.

Authors:  M S Highley; E A De Bruijn
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

Review 3.  Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics.

Authors:  P H Hinderling
Journal:  Pharmacol Rev       Date:  1997-09       Impact factor: 25.468

4.  Stevens-Johnson syndrome induced by methazolamide treatment.

Authors:  S Shirato; F Kagaya; Y Suzuki; S Joukou
Journal:  Arch Ophthalmol       Date:  1997-04

5.  Inhibition of carbonic anhydrase activity of whole erythrocytes.

Authors:  P J Wistrand; P Bååthe
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1968

6.  Diffusion of sulfonamides in aqueous buffers and into red cells.

Authors:  L B Holder; S L Hayes
Journal:  Mol Pharmacol       Date:  1965-11       Impact factor: 4.436

7.  In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics.

Authors:  G R Iyer; R A Bellantone; D R Taft
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

8.  The pharmacology of methazolamide in relation to the treatment of glaucoma.

Authors:  T H Maren; J R Haywood; S K Chapman; T J Zimmerman
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-08       Impact factor: 4.799

9.  Blood disposition and urinary excretion kinetics of methazolamide following oral administration to human subjects.

Authors:  D R Taft; S Nordt; G R Iyer; M H Schwenk
Journal:  Biopharm Drug Dispos       Date:  1998-09       Impact factor: 1.627

10.  Time course and disposition of methazolamide in human plasma and red blood cells.

Authors:  W F Bayne; F T Tao; G Rogers; L C Chu; F Theeuwes
Journal:  J Pharm Sci       Date:  1981-01       Impact factor: 3.534
View more
  1 in total

1.  Crystal structure of human carbonic anhydrase II at 1.95 A resolution in complex with 667-coumate, a novel anti-cancer agent.

Authors:  Matthew D Lloyd; Richard L Pederick; Ramanathan Natesh; L W Lawrence Woo; Atul Purohit; Michael J Reed; K Ravi Acharya; Barry V L Potter
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.